AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CARCLO PLC

Report Publication Announcement Jun 30, 2022

5252_rns_2022-06-30_a7698b3a-fc08-42ea-a4e5-2a7d6a13b275.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 7848Q

Carclo plc

30 June 2022

30 June 2022

Carclo plc

Notice of Investor Presentation

Carclo plc is pleased to announce that Nick Sanders, Executive Chair, and Phil White, Chief Financial Officer, will provide a live presentation relating to the Preliminary Results for the year ended 31 March 2022 via the Investor Meet Company platform on 5 July 2022 at 10.00 am (BST). 

The presentation is open to all existing and potential shareholders.  Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9.00 am (BST) on 4 July 2022 or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Carclo plc via the following link:

https://www.investormeetcompany.com/carclo-plc/register-investor

Investors who already follow Carclo plc on the Investor Meet Company platform will be invited automatically.

About Carclo plc

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange. The Group is a global provider of value-adding engineered solutions for the medical, optical and aerospace industries.

LEI: 21380078MEM399JPI956

Enquiries:
Carclo plc 01924 268040
Nick Sanders - Executive Chair
FTI Consulting 020 3727 1340
Nick Hasell / Susanne Yule

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DOCBKKBDABKKFAN

Talk to a Data Expert

Have a question? We'll get back to you promptly.